[4].Soojin Lee, et al. Unveiling Prognostic Biomarkers in IgA Nephropathy: A Chromatin Accessibility Approach Using Peripheral Immune Cells. 2024ASN abstract TH-PO542. [5].Cheng, et al. Serum GDF15 Could Predict Cardio...
➤ 世界华人肾脏病学会常委 信源:ASN Kidney Week 2024 官网 Abstract 链接:https://www.asn-online.org/education/kidneyweek/archives/ 以上研究均出自 ASN 官网 e-Poster,可通过以下链接搜索编号获取: https://asn.apprisor.org/epsAbstractASN.cfm?id=1 审批编号:CN-146215 有效期至:2025-1-25 声明:仅...
[4] Safety and Efficacy of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Nondialysis-Dependent CKD (NDD-CKD). ASN 2024. ABSTRACT: TH-PO898. [5] Hemoglobin Rate of Rise during Initial Treatment in Nondialysis-Dependent Patients with CKD and Anemi...
[1] Comparative Effectiveness of Roxadustat vs. Erythropoiesis-Stimulating Agents (ESAs) on Anemia and Kidney Outcomes among Patients with CKD: A Retrospective Cohort Study. ASN 2024. ABSTRACT: FR-PO1161. [2] Recombinant Human Erythropoietin (rhEPO)-Fc for Renal Anaemia in Chinese Patients on Ha...
【2】Chen Jianghua,et al.Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study. ASN 2024. ABSTRACT: TH-PO888 【3】American Society of Nephrology (ASN). https://www.asnonline.org/education/kidneyweek/ ...
ABSTRACT SUBMISSIONS Deadline for abstracts submissions:11:59 pm EST, January 5th, 2024. Acceptance notification will be sent out in February 2024. To submit an abstract, you will need to complete your registration first. 点此提交摘要>>>Submit Abstract>>> ...
全球最具影响力的肾脏病学术大会——美国肾脏病学会2024年度肾脏周(ASN Kidney Week 2024)于上周在美国圣地亚哥举行,来自世界各地的顶尖专家向全球肾病学者分享了最新研究成果。 智康弘义在本次会议的口头摘要环节(Oral Abstract Session)中介绍了核心产品SC0062胶囊治疗IgA肾病的最新临床试验结果。
【2】Chen Jianghua,et al.Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study. ASN 2024. ABSTRACT: TH-PO888 【3】AmericanSociety of Nephrology (ASN).网页链接 ...
【2】Chen Jianghua,et al.Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study. ASN 2024. ABSTRACT: TH-PO888 【3】American Society of Nephrology (ASN). https://www.asnonline.org/education/kidneyweek/ ...
【2】Chen Jianghua,et al.Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study. ASN 2024. ABSTRACT: TH-PO888 【3】American Society of Nephrology (ASN). https://www.asnonline.org/education/kidneyweek/ ...